Lexaria to test DehydraTECH GLP-1 product for weight loss, diabetes [Seeking Alpha]
Lexaria Bioscience Corp. (LEXX)
Company Research
Source: Seeking Alpha
semaglutide or liraglutide, and DehydraTECH-CBD in the treatment of weight loss and diabetes. DehydraTECH-GLP-1 is a GLP-1 drug processed with the company's DehydraTECH drug delivery technology, while DehydraTECH-CBD is a cannabidiol product. The company will be testing the products alone and in combination for weight loss and blood glucose level control, according to a statement. Lexaria said the GLP-1 formulations to be tested will include Novo Nordisk's ( NVO ) semaglutide or liraglutide. Semaglutide is marketed by Novo Nordisk under the names Wegovy, Ozempic and Rybelsus. Liraglutide is sold under the names Victoza and Saxenda. Recommended For You Recommended For You Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
LEXX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEXX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEXX alerts
High impacting Lexaria Bioscience Corp. news events
Weekly update
A roundup of the hottest topics
LEXX
News
- Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 DrugsAccesswire
- Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance [Yahoo! Finance]Yahoo! Finance
- Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and IssuanceAccesswire
- Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study [Yahoo! Finance]Yahoo! Finance
- Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 StudyAccesswire
LEXX
Analyst Actions
- 3/5/24 - Maxim Group
LEXX
Sec Filings
- 5/2/24 - Form D
- 4/30/24 - Form 8-K
- 4/25/24 - Form SC
- LEXX's page on the SEC website